‘Smart’ cancer drugs share top honours in drug innovation prize

October 21, 2003
prix galien

The innovative science behind two breakthrough cancer drugs, Novartis’ leukaemia treatment Glivec and Roche’s breast cancer drug Herceptin, has been …

NHS palliative care gets

October 21, 2003

Novartis questions AstraZeneca cancer data

October 21, 2003

Novartis has questioned the evidence behind a UK licence extension to AstraZeneca breast cancer drug Arimidex.The Medicines Control Agency licence …

Kogan steps down from troubled Schering

October 21, 2003

Richard Jay Kogan has stepped down as Chairman of Schering-Plough and will relinquish his post as Chief Executive and President …

Cozaar gains renal protection licence

October 21, 2003

Merck Sharpe & Dohme's Cozaar has gained a new UK licence for renal protection in patients with type II diabetes …

Lilly to launch three products in 2003

October 21, 2003

Eli Lilly is to embark on an ambitious product launch schedule over the next two years to overcome the patent …

Bayer open to takeover bids

October 21, 2003

The Chief Executive of Bayer has conceded the company cannot continue alone, and has now declared the company open to …

Alzheimer drugs rationing continues despite NICE guidelines

October 21, 2003

Alzheimer's patients in a quarter of all health authorities are still not receiving the latest medicines despite NICE guidance being …

Europe to mimic US research ‘clusters’

October 21, 2003

New networks of excellence in pharmaceutical research must be established if Europe is to catch up with world leading US …

Crestor approval lifts AstraZeneca

October 21, 2003

AstraZeneca has been boosted by the first regulatory approval in the Netherlands of Crestor, its 'superstatin' cholesterol treatment.The drug is …

OTC advertising regulations to be relaxed

October 21, 2003

A ban on advertising some OTC medicines could be lifted as part of the Government drive to create a patient-centred …

Patients to report drug side-effects to NHS

October 21, 2003

Patients will be able to report adverse reactions to medicines direct to the NHS from next year, the Government has …

AZ launches Zomig nasal spray

October 21, 2003

AstraZeneca has launched a new fast acting nasal spray version of its migraine treatment Zomig.The product is intended to bypass …

The Consumer Age

October 21, 2003
Medical Communications empowered, patients

The growing influence of patient advocacy groups (PAGs) such as the Patients Association is evidence of patient power flexing its …

Latest content